Aravive Inc (DELISTED) (ARAV:DL)
0.0401
0.00 (0.00%)
USD |
NASDAQ |
Feb 07, 16:00
Aravive Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -3.35K% |
| December 31, 2022 | -1.98K% |
| September 30, 2022 | -316.0% |
| June 30, 2022 | -1.14K% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.32K% |
| September 30, 2021 | -459.6% |
| June 30, 2021 | -187.5% |
| March 31, 2021 | -3.13K% |
| December 31, 2020 | -71.17% |
| September 30, 2020 |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | -99.67% |
| March 31, 2019 | -276.9% |
| December 31, 2018 | -3.72K% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 77.82% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.35K%
Minimum
Mar 2023
-71.17%
Maximum
Dec 2020
-1.20K%
Average
-1.14K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Esperion Therapeutics Inc | -174.7% |
| Processa Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -107.0% |
| Operating Margin (Quarterly) | -323.4% |
| Return on Net Operating Assets | -1.12K% |